Our Approach
Project Initiation and Onboarding
We typically initiate projects within two to three weeks of proposal acceptance. During this time, we manage project onboarding and procure any necessary materials. Our analytical team plays a crucial role in onboarding new methods, confirming their suitability, and ensuring readiness for the subsequent stages of your project. This integrated approach allows us to deliver rapid feedback and supports efficient formulation development.
Formulation Development and Dosage Forms
We support projects from early-stage proof of concept through to full drug product development. Our expertise spans traditional solid dose forms such as granulation, tableting, and coating, as well as advanced technologies like spray drying and jet milling for bioavailability enhancement and particle engineering. We focus on formulation selection and prototype testing, carrying out dissolution and tablet testing in-house to ensure your project is ready for scale-up.
Stability Testing
Stability testing is a key component of our development process. We offer both ICH-compliant and informal stability testing methods, with in-house ICH chambers to support these studies. We also utilise ASAPprime stability modelling, which provides rapid predictive data within a month. This capability helps predict a product’s shelf life over three to five years, offering insights for clients looking to accelerate their development timelines.
Clinical Manufacturing
Our clinical manufacturing services cover Phase I, II, and III clinical supplies. From our MHRA-approved GMP facility in Nottingham, we operate ten individual manufacturing suites capable of handling a variety of dosage forms, including oral solids, bulk dry powders, dry powder inhalers, nasal suspensions, and solutions.
Get in touch.
If you’re looking to work with a CDMO that can support your product from preclinical development to market and beyond, then we’re here to help.
